
Friday, August 30, 2024 9:04:57 PM
If U don't mind I'll do a mini critique some time
Re CRMD ...and their cath loc . I had briefly discussed cath infections with my smarter half some time ago.. She sees 1-2 cases a mth
Rate of infection
The event rate per 1000 catheter-days was:
0.13 for DefenCath
0.46 for heparin
It's only used in central venous lines. correct ? . Most access in dialysis clinics are thru fistula's in the arm .
Are they included in the dialysis bundle ??...which is supposed to cover all things dialysis .
Above is just quick thoughts on a Fri eve and may be totally incorrect
I usually don't hold a Co once a drug is approved ....Launch usually longer and harder then most expect and -ve surprises seem inevitable ...AMRN case in pt.
Currently in UNCY and ARDX as I expect the Kidney Patient Act to pass
Also in EWTX, VERA, RZLT, OCUL,TLPH , FULC, RNA , KYMR ...and of course AMRN . Why AMRN ...to remind myself to always sell on FDA approval. ..:--)
Kiwi
Recent TLPH News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 04/17/2025 08:30:50 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/03/2025 09:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2025 08:31:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2025 08:29:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2025 08:28:23 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/03/2025 01:59:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2025 09:09:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:01:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2025 08:11:39 PM
- Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 03/31/2025 08:05:00 PM
- Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million • PR Newswire (US) • 03/31/2025 12:30:00 PM
- Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 • PR Newswire (US) • 03/26/2025 08:38:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2025 11:52:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 09:49:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2025 09:47:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2025 09:09:30 PM
- Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study • PR Newswire (US) • 01/14/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 09:31:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2024 11:05:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:22:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2024 09:20:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/02/2024 05:31:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 09:30:26 PM
- Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors • PR Newswire (US) • 11/25/2024 12:27:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 10:15:14 PM
Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory • CATV • Apr 22, 2025 8:30 AM
Glidelogic Corp. (OTCQB: GDLG) Highlights Independent SOTA Evaluation of ResearchMind Platform • GDLG • Apr 22, 2025 6:54 AM
UAV Corp to Launch Inflation Test of SA-70 Airship This Week-A Gateway to High-Value Government and Defense Contracts • UMAV • Apr 21, 2025 1:30 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM